Hershkovitz L - Search Results

1

Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats.

Ankri C, Hershkovitz O, Hershkovitz L, Brami M, Levy R, Sarig H, Souli E, Reicher B, Amor-Baroukh V, Mevorach D, Nyska A. Ankri C, et al. Among authors: hershkovitz l. Pharmaceutics. 2024 Mar 20;16(3):426. doi: 10.3390/pharmaceutics16030426. Pharmaceutics. 2024. PMID: 38543320 Free PMC article.

2

A Secure Base for Entrepreneurship: Attachment Orientations and Entrepreneurial Tendencies.

Segal S, Mikulincer M, Hershkovitz L, Meir Y, Nagar T, Maaravi Y. Segal S, et al. Among authors: hershkovitz l. Behav Sci (Basel). 2023 Jan 9;13(1):61. doi: 10.3390/bs13010061. Behav Sci (Basel). 2023. PMID: 36661633 Free PMC article.

3

The ability of the instrumented tandem walking tests to discriminate fully ambulatory people with MS from healthy adults.

Grinberg Y, Berkowitz S, Hershkovitz L, Malcay O, Kalron A. Grinberg Y, et al. Among authors: hershkovitz l. Gait Posture. 2019 May;70:90-94. doi: 10.1016/j.gaitpost.2019.02.022. Epub 2019 Feb 26. Gait Posture. 2019. PMID: 30831545

4

The contribution of the instrumented Timed-Up-and-Go test to detect falls and fear of falling in people with multiple sclerosis.

Hershkovitz L, Malcay O, Grinberg Y, Berkowitz S, Kalron A. Hershkovitz L, et al. Mult Scler Relat Disord. 2019 Jan;27:226-231. doi: 10.1016/j.msard.2018.10.111. Epub 2018 Oct 27. Mult Scler Relat Disord. 2019. PMID: 30415024

5

Cognitive-motor interference in multiple sclerosis: What happens when the gait speed is fixed?

Malcay O, Grinberg Y, Berkowitz S, Hershkovitz L, Kalron A. Malcay O, et al. Among authors: hershkovitz l. Gait Posture. 2017 Sep;57:211-216. doi: 10.1016/j.gaitpost.2017.06.024. Epub 2017 Jun 23. Gait Posture. 2017. PMID: 28667902

6

Prohedonic Effect of Cannabidiol in a Rat Model of Depression.

Shoval G, Shbiro L, Hershkovitz L, Hazut N, Zalsman G, Mechoulam R, Weller A. Shoval G, et al. Among authors: hershkovitz l. Neuropsychobiology. 2016;73(2):123-9. doi: 10.1159/000443890. Epub 2016 Mar 25. Neuropsychobiology. 2016. PMID: 27010632

7

Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions.

Ortenberg R, Sapir Y, Raz L, Hershkovitz L, Ben Arav A, Sapoznik S, Barshack I, Avivi C, Berkun Y, Besser MJ, Ben-Moshe T, Schachter J, Markel G. Ortenberg R, et al. Among authors: hershkovitz l. Mol Cancer Ther. 2012 Jun;11(6):1300-10. doi: 10.1158/1535-7163.MCT-11-0526. Epub 2012 Mar 30. Mol Cancer Ther. 2012. PMID: 22466331

8

Regulation of cancer aggressive features in melanoma cells by microRNAs.

Greenberg E, Hershkovitz L, Itzhaki O, Hajdu S, Nemlich Y, Ortenberg R, Gefen N, Edry L, Modai S, Keisari Y, Besser MJ, Schachter J, Shomron N, Markel G. Greenberg E, et al. Among authors: hershkovitz l. PLoS One. 2011 Apr 25;6(4):e18936. doi: 10.1371/journal.pone.0018936. PLoS One. 2011. PMID: 21541354 Free PMC article.

9

Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy.

Itzhaki O, Hovav E, Ziporen Y, Levy D, Kubi A, Zikich D, Hershkovitz L, Treves AJ, Shalmon B, Zippel D, Markel G, Shapira-Frommer R, Schachter J, Besser MJ. Itzhaki O, et al. Among authors: hershkovitz l. J Immunother. 2011 Mar;34(2):212-20. doi: 10.1097/CJI.0b013e318209c94c. J Immunother. 2011. PMID: 21304398

10

Focus on adoptive T cell transfer trials in melanoma.

Hershkovitz L, Schachter J, Treves AJ, Besser MJ. Hershkovitz L, et al. Clin Dev Immunol. 2010;2010:260267. doi: 10.1155/2010/260267. Epub 2010 Dec 26. Clin Dev Immunol. 2010. PMID: 21234353 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters